Laboratoire de Spectrométrie de Masse des Interactions et des Systèmes (LSMIS) UMR 7140 (Unistra-CNRS), Université de Strasbourg, France; Université Paris Cité, Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), CNRS, Inserm, Faculté de sciences pharmaceutiques et biologiques, Paris, France.
Université Paris Cité, Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS), CNRS, Inserm, Faculté de sciences pharmaceutiques et biologiques, Paris, France; Laboratoire de Toxicologie Biologique, Hôpital Lariboisière, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Feb 15;1234:123974. doi: 10.1016/j.jchromb.2023.123974. Epub 2024 Jan 8.
Due to the separation technique employed, capillary electrophoresis coupled to mass spectrometry (CE-MS) analysis performances are significantly influenced by the chemical composition and the complexity of the sample. In various applications, that impact has prevented the use of CE-MS for the characterization and quantification of proteins in biological samples. Here we present the development and evaluation and a sample preparation procedure, based on affinity purification, for the specific extraction of the monoclonal antibody (mAbs) infliximab from human serum in order to perform subsequent proteolytic digestion and CE-MS/MS analysis. Three distinctive sample preparation strategies were envisaged. In each case, the different steps composing the protocol were thoroughly optimized and evaluated in order to provide a sample preparation addressing the important complexity of serums samples while providing an optimal compatibility with CE-MS/MS analysis. The different sample preparation strategies were assessed concerning the possibility to achieve an appropriate absolute quantification of the mAbs using CE-MS/MS for samples mimicking patient serum samples. Also, the possibility to perform the characterization of several types of post-translational modifications (PTMs) was evaluated. The sample preparation protocols allowed the quantification of the mAbs in serums samples for concentration as low as 0.2 µg·mL (2.03 nM) using CE-MS/MS analysis, also the possibility to characterize and estimate the modification level of PTMs hotspots in a consistent manner. Results allowed to attribute the effect on the electrophoretic separation of the different steps composing sample preparation. Finally, they demonstrated that sample preparation for CE-MS/MS analysis could benefit greatly for the extended applicability of this type of analysis for complex biological matrices.
由于所采用的分离技术,毛细管电泳与质谱联用(CE-MS)分析的性能受到样品的化学成分和复杂性的显著影响。在各种应用中,这种影响阻止了 CE-MS 用于生物样品中蛋白质的表征和定量。在这里,我们提出了一种开发和评估方法,以及一种基于亲和纯化的样品制备程序,用于从人血清中特异性提取单克隆抗体(mAbs)英夫利昔单抗,以便进行后续的蛋白水解消化和 CE-MS/MS 分析。设想了三种不同的样品制备策略。在每种情况下,对组成方案的不同步骤进行了彻底优化和评估,以提供一种样品制备方法,解决血清样品的重要复杂性问题,同时与 CE-MS/MS 分析具有最佳兼容性。针对使用 CE-MS/MS 对模拟患者血清样品的样品进行适当的绝对定量的可能性,评估了不同的样品制备策略。还评估了进行几种类型的翻译后修饰(PTM)的表征的可能性。样品制备方案允许使用 CE-MS/MS 对血清样品中的 mAbs 进行定量,浓度低至 0.2 μg·mL(2.03 nM),还可以以一致的方式对 PTM 热点进行表征和估计修饰水平。结果归因于样品制备过程中不同步骤对电泳分离的影响。最后,它们证明了用于 CE-MS/MS 分析的样品制备可以极大地扩展这种类型的分析在复杂生物基质中的应用。